The Debate Over New Alzheimer’s Disease Drugs: Breakthrough or False Hope?
Lecanemab and donanemab, two novel medications for Alzheimer’s disease, are gaining a lot of interest. These medications are thought to be the first to reduce the progression of the illness. Some people think this is a significant advancement, but others aren’t sure. They claim that the medications are costly and might not be effective. A … Read more